:

Wenyue Chen1, Zhengqiang Li1, Jin Tang1

  • 1Department of Oral and Maxillofacial Surgery, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, China.

PubMed
概括

头部和部状细胞癌 (HNSCC) 治疗面临着免疫检查点抑制剂 (ICI) 的挑战. 树突细胞 (DC) 免疫疗法通过改善HNSCC的抗瘤免疫反应来增强ICI疗效.